Core Laboratories (CLB) Misses Q2 EPS by 2c

Core Laboratories (NYSE: CLB) reported Q2 EPS of $0.12, $0.02 worse than the analyst estimate of $0.14. Revenue for the quarter came in at $120.9 million versus the consensus estimate of $121.94 million.

For earnings history and earnings-related data on Core Laboratories (CLB) click here.

You May Also Be Interested In

• Is Treasury selloff a major issue for stock market bulls?
• Johnson Rice Upgrades Core Laboratories (CLB) to Buy
• Securitize Corp (SECZ) PT Lowered to $10 at Benchmark as Stock Plummets Post Q2 Earnings